Showing results (1811-1820 of 2,075) with videos related to

Sort By:
Pageof 208
Scientific Reports|November 11, 2018
Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosisLara Maria Krämer, Johannes Brettschneider, Jochen K Lennerz, et al.
Analytical Chemistry|April 7, 2025
Single-Molecule Liquid Biopsy Detects Low- and High-Abundance Protein Markers Simultaneously for Pancreatic Cancer DiagnosisXinjian Wang, Yudong Che, Songlin Liu, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Cell|July 19, 2016
Presynaptic Excitation via GABAB Receptors in Habenula Cholinergic Neurons Regulates Fear Memory ExpressionJuen Zhang, Lubin Tan, Yuqi Ren, et al.
BMC Plant Biology|June 23, 2010
Genome-wide characterization of the biggest grass, bamboo, based on 10,608 putative full-length cDNA sequencesZhenhua Peng, Tingting Lu, Lubin Li, et al.
International Journal of Epidemiology|January 1, 1997
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkersS A Bingham, C Gill, A Welch, et al.
Diabetes Care|August 6, 2014
Cognitive function and the risk for diabetes among young menGilad Twig, Israel Gluzman, Amir Tirosh, et al.
European Journal of Medicinal Chemistry|January 9, 2020
Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of PlasmodiumXiaofei Liang, Zongru Jiang, Zhenghui Huang, et al.
Acta Pharmaceutica Sinica. B|September 30, 2021
Design, synthesis, and biological evaluation of multiple targeting antimalarialsYiqing Yang, Tongke Tang, Xiaolu Li, et al.
Heliyon|April 10, 2023
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virusNancy E Hernandez, Wojciech Jankowski, Rahel Frick, et al.
Pageof 208